Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 2 |
2017 | 2 |
2018 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment.
PLoS One. 2018 Jun 7;13(6):e0198141. doi: 10.1371/journal.pone.0198141. eCollection 2018.
PLoS One. 2018.
PMID: 29879129
Free PMC article.
Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform.
Morry J, Ngamcherdtrakul W, Gu S, Reda M, Castro DJ, Sangvanich T, Gray JW, Yantasee W.
Morry J, et al.
Mol Cancer Ther. 2017 Apr;16(4):763-772. doi: 10.1158/1535-7163.MCT-16-0644. Epub 2017 Jan 30.
Mol Cancer Ther. 2017.
PMID: 28138033
Free PMC article.
Item in Clipboard
Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles.
Morry J, Ngamcherdtrakul W, Yantasee W.
Morry J, et al.
Redox Biol. 2017 Apr;11:240-253. doi: 10.1016/j.redox.2016.12.011. Epub 2016 Dec 16.
Redox Biol. 2017.
PMID: 28012439
Free PMC article.
Review.
Item in Clipboard
Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.
Ngamcherdtrakul W, Castro DJ, Gu S, Morry J, Reda M, Gray JW, Yantasee W.
Ngamcherdtrakul W, et al.
Cancer Treat Rev. 2016 Apr;45:19-29. doi: 10.1016/j.ctrv.2016.02.005. Epub 2016 Feb 22.
Cancer Treat Rev. 2016.
PMID: 26930249
Free PMC article.
Review.
Item in Clipboard
Cite
Cite